Scinovex
review Open AccessTop 1% cited

Cardiovascular disease in dialysis patients

Nephrology Dialysis Transplantation · 2018 · Vol. 33(suppl_3) · pp. iii28–iii34
Mario CozzolinoMichela ManganoAndrea StucchiPaola CiceriFerruccio ConteAndrea Galassi

Abstract

Cardiovascular disease (CVD) is a highly common complication and the first cause of death in patients with end-stage renal disease (ESRD) on haemodialysis (HD). In this population, mortality due to CVD is 20 times higher than in the general population and the majority of maintenance HD patients have CVD. This is likely due to ventricular hypertrophy as well as non-traditional risk factors, such as chronic volume overload, anaemia, inflammation, oxidative stress, chronic kidney disease-mineral bone disorder and other aspects of the 'uraemic milieu'. Better understanding the impact of these numerous factors on CVD would be an important step for prevention and treatment. In this review we focus non-traditional CVD risk factors in HD patients.

Dialysis and Renal Disease ManagementParathyroid Disorders and TreatmentsNeurological and metabolic disordersMedicineIntensive care medicineDialysisDiseaseHemodialysisKidney diseaseInternal medicineCardiology

MeSH terms

Cardiovascular DiseasesRenal DialysisHumansKidney Failure, ChronicRisk Factors

Funding

  • Baxter Healthcare Corporation
Citations
549
FWCI
25.09
field-weighted impact
References
61
Percentile
100%
vs. same field & year
Citations per year
Cited by
Evaluation of lipid profile in dialysis dependent chronic kidney disease
International Journal of Advanced Research in Medicine · 2020 · 0 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.